Libby Jones is the Program Director of Global Health Advocacy Incubator, GHAI’s Overdose Prevention Initiative. Libby leads the Initiative’s advocacy efforts, advancing federal policies to reduce the overdose death rate in the United States by expanding access to treatment and promoting harm reduction. Prior to joining GHAI, Libby served as government relations officer at the Pew Charitable Trusts’ substance use prevention and treatment initiative. Libby also has more than 15 years of experience working in the U.S. federal government, having held various positions in the U.S. Food and Drug Administration, Department of Commerce, Department of Justice.
Libby holds a Masters Degree in Human Rights from the London School of Economics and Political Science, and received a Bachelor of Arts degree from the College of William and Mary.
How should law enforcement, fire, hazmat, and hospitals respond to exposure to chemicals and drugs. Should hazmat to sterilize the area where a bag...
Cannabis has many different chemicals, namely cannabinoids that have pharmaceutical benefits. Learn about FDA approved cannabinoid research. There is a big difference between medications...
Get ready to have your jaw drop when you learn about babies who overdose on drugs. Babies and kids under 5 are getting into...